ONCBIOMUNE
.OncBioMune is a biopharmaceutical company that develops medicines and vaccines to treat novel cancer and stimulate the immune system.
ONCBIOMUNE
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2005-01-01
Address:
Baton Rouge, Louisiana, United States
Country:
United States
Website Url:
http://www.oncbiomune.com
Total Employee:
1+
Status:
Active
Contact:
+1 225-227-2384
Email Addresses:
[email protected]
Current Employees Featured
Official Site Inspections
http://www.oncbiomune.com
- Host name: 172.67.136.79
- IP address: 172.67.136.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OncBioMune"
OncBioMune - Crunchbase Company Profile & Funding
Organization. OncBioMune . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About.OncBioMune is a biopharmaceutical company that develops …See details»
About Us | OncBioMune Pharmaceuticals Inc.
Prior to joining OncBioMune, Dr. Barnett served at Puma Biotechnology, Inc. since August 2016 most recently as a Vice President and Head of Medical Affairs. Prior to his time with Puma, Dr. …See details»
Oncbiomune, Inc.
Oncbiomune, a biotechnology company specializing in innovative cancer treatment, has proprietary rights to a breast cancer vaccine (patent #5,478,556) and prostate cancer vaccine …See details»
OncBioMune Company Profile 2024: Valuation, Funding
OncBioMune was founded in 2005. Where is OncBioMune headquartered? OncBioMune is headquartered in Baton Rouge, LA. What is the size of OncBioMune? OncBioMune has 5 total …See details»
OncBioMune Pharmaceuticals Company Profile - Craft
Apr 27, 2022 OncBioMune specializes in innovative cancer research. The Company owns the proprietary rights to a therapeutic cancer vaccine and patent-pending targeted therapies. The …See details»
OncBioMune - Contacts, Employees, Board Members, Advisors
.OncBioMune is a biopharmaceutical company that develops medicines and vaccines to treat novel cancer and stimulate the immune system. Search Crunchbase. Start Free Trial . Chrome …See details»
Molecular profiling company OncBioMune changes name to …
Sep 24, 2020 OncBioMune Pharmaceuticals Inc. changed its name to Theralink Technologies Inc., effective Sept. 24. The name change follows the company's asset purchase of …See details»
Oncbiomune LLC - Company Profile and News - Bloomberg Markets
Company profile page for Oncbiomune LLC including stock price, company news, executives, board members, and contact informationSee details»
OncBioMune Provides Corporate Update, Nearly 50 Drug …
May 9, 2017 OncBioMune Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company engaged in the development of targeted cancer therapies and a proprietary vaccine …See details»
OncBioMune Appoints Dr. Mick Ruxin as President & CEO and …
Jun 10, 2020 OncBioMune's new team has the potential to substantially reduce the morbidity and mortality of cancer patients," said Mick Ruxin, M.D., OncBioMune's newly appointed …See details»
Investors | OncBioMune Pharmaceuticals Inc.
OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary Vaccine Technology …See details»
OncBioMune Preparing to Initiate Trials of Novel - GlobeNewswire
Oct 17, 2017 In the coming weeks, OncBioMune management will be scheduling CA-125 manufacturing under cGMP standards and conducting meetings with contract research …See details»
OncBioMune Pharmaceuticals Inc Signs MOU for Joint Venture …
Mar 29, 2016 OncBioMune Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is …See details»
Theralink Technologies - Crunchbase Company Profile & Funding
Theralink Assay: A diagnostic tool using Reverse Phase Protein Array (RPPA) technology to measure the abundance and activation of cell surface receptor proteins and their downstream …See details»
OncBioMune, AqVida Partner for Commercializing Cancer and …
Apr 26, 2017 OncBioMune Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, …See details»
Events and Presentations | OncBioMune Pharmaceuticals Inc.
November 2, 2018 - 2018 Global Summit on Genitourinary Malignancies - OncBioMune Pharmaceuticals CEO Dr. Jonathan Head presented alongside other well renowned faculty …See details»
Immuno-oncology Biomarkers - Oncimmune
Antibody biomarker discovery to improve the development of immuno-oncology therapies using ImmunoINSIGHTSâ„¢ Despite the enormous potential of cancer immunotherapy, many patients …See details»
Press Releases | OncBioMune Pharmaceuticals Inc.
OncBioMune Announces Compelling Pre-Clinical Data for its CD71-Targeted Chemotherapy, PGT, in Models of Lung, Pancreatic and Ovarian Cancers. July 15th, 2019 | 0 Comments. …See details»
Breast Cancer | OncBioMune Pharmaceuticals Inc.
Breast cancers and other epithelial malignancies are antigenic and elicit lymphocyte responses in the autologous host, and patients that express good host immunity to their tumor have better …See details»